vs
Side-by-side financial comparison of Clearfield, Inc. (CLFD) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $34.3M, roughly 1.8× Clearfield, Inc.). Clearfield, Inc. runs the higher net margin — -1.8% vs -70.9%, a 69.1% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -3.2%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-2.4M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -3.5%).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
CLFD vs CTKB — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.3M | $62.1M |
| Net Profit | $-614.0K | $-44.1M |
| Gross Margin | 33.2% | 52.9% |
| Operating Margin | -5.3% | -9.0% |
| Net Margin | -1.8% | -70.9% |
| Revenue YoY | -3.2% | 8.1% |
| Net Profit YoY | 67.8% | -557.1% |
| EPS (diluted) | $-0.04 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.3M | $62.1M | ||
| Q3 25 | $23.4M | $52.3M | ||
| Q2 25 | $49.9M | $45.6M | ||
| Q1 25 | $47.2M | $41.5M | ||
| Q4 24 | $29.7M | $57.5M | ||
| Q3 24 | $5.6M | $51.5M | ||
| Q2 24 | $48.8M | $46.6M | ||
| Q1 24 | $36.9M | $44.9M |
| Q4 25 | $-614.0K | $-44.1M | ||
| Q3 25 | $-9.1M | $-5.5M | ||
| Q2 25 | $1.6M | $-5.6M | ||
| Q1 25 | $1.3M | $-11.4M | ||
| Q4 24 | $-1.9M | $9.6M | ||
| Q3 24 | — | $941.0K | ||
| Q2 24 | $-447.0K | $-10.4M | ||
| Q1 24 | $-5.9M | $-6.2M |
| Q4 25 | 33.2% | 52.9% | ||
| Q3 25 | 53.2% | 52.7% | ||
| Q2 25 | 30.5% | 52.3% | ||
| Q1 25 | 30.1% | 48.6% | ||
| Q4 24 | 29.2% | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | 21.9% | 54.6% | ||
| Q1 24 | 7.7% | 51.3% |
| Q4 25 | -5.3% | -9.0% | ||
| Q3 25 | 10.3% | -17.6% | ||
| Q2 25 | 3.0% | -23.3% | ||
| Q1 25 | 0.6% | -36.1% | ||
| Q4 24 | -6.9% | 5.2% | ||
| Q3 24 | — | -8.2% | ||
| Q2 24 | -4.7% | -18.3% | ||
| Q1 24 | -26.4% | -23.9% |
| Q4 25 | -1.8% | -70.9% | ||
| Q3 25 | -38.8% | -10.5% | ||
| Q2 25 | 3.2% | -12.2% | ||
| Q1 25 | 2.8% | -27.5% | ||
| Q4 24 | -6.4% | 16.8% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | -0.9% | -22.4% | ||
| Q1 24 | -16.0% | -13.8% |
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $-0.65 | — | ||
| Q2 25 | $0.11 | — | ||
| Q1 25 | $0.09 | — | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.40 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.4M | $90.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $249.7M | $341.7M |
| Total Assets | $268.1M | $461.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.4M | $90.9M | ||
| Q3 25 | $106.0M | $93.3M | ||
| Q2 25 | $117.2M | $75.5M | ||
| Q1 25 | $112.0M | $95.3M | ||
| Q4 24 | $113.0M | $98.7M | ||
| Q3 24 | $129.0M | $162.3M | ||
| Q2 24 | $123.8M | $177.9M | ||
| Q1 24 | $142.9M | $168.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $249.7M | $341.7M | ||
| Q3 25 | $256.2M | $378.6M | ||
| Q2 25 | $264.5M | $377.6M | ||
| Q1 25 | $265.9M | $379.6M | ||
| Q4 24 | $267.4M | $395.7M | ||
| Q3 24 | $275.8M | $385.5M | ||
| Q2 24 | $274.6M | $389.1M | ||
| Q1 24 | $279.2M | $392.6M |
| Q4 25 | $268.1M | $461.5M | ||
| Q3 25 | $306.2M | $494.9M | ||
| Q2 25 | $314.7M | $493.3M | ||
| Q1 25 | $310.9M | $482.6M | ||
| Q4 24 | $303.2M | $499.5M | ||
| Q3 24 | $315.3M | $491.2M | ||
| Q2 24 | $318.1M | $483.7M | ||
| Q1 24 | $315.4M | $492.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $-771.0K |
| Free Cash FlowOCF − Capex | $-2.4M | $-1.8M |
| FCF MarginFCF / Revenue | -7.1% | -2.9% |
| Capex IntensityCapex / Revenue | 2.9% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | $-771.0K | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | $7.9M | $108.0K | ||
| Q1 25 | $3.0M | $-125.0K | ||
| Q4 24 | $7.2M | $2.0M | ||
| Q3 24 | $22.2M | $13.2M | ||
| Q2 24 | $4.0M | $6.2M | ||
| Q1 24 | $-5.7M | $4.0M |
| Q4 25 | $-2.4M | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | $7.5M | $-1.5M | ||
| Q1 25 | $654.0K | $-974.0K | ||
| Q4 24 | $5.1M | $1.1M | ||
| Q3 24 | $18.2M | $12.2M | ||
| Q2 24 | $2.8M | $5.2M | ||
| Q1 24 | $-7.7M | $3.4M |
| Q4 25 | -7.1% | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | 15.1% | -3.2% | ||
| Q1 25 | 1.4% | -2.3% | ||
| Q4 24 | 17.1% | 1.9% | ||
| Q3 24 | 323.0% | 23.7% | ||
| Q2 24 | 5.8% | 11.0% | ||
| Q1 24 | -20.8% | 7.6% |
| Q4 25 | 2.9% | 1.6% | ||
| Q3 25 | 2.0% | 1.3% | ||
| Q2 25 | 0.8% | 3.5% | ||
| Q1 25 | 5.1% | 2.0% | ||
| Q4 24 | 7.0% | 1.6% | ||
| Q3 24 | 71.4% | 2.0% | ||
| Q2 24 | 2.5% | 2.3% | ||
| Q1 24 | 5.3% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLFD
Segment breakdown not available.
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
